173 related articles for article (PubMed ID: 33753999)
1. GPRC5A: An emerging prognostic biomarker for predicting malignancy of Pancreatic Cancer based on bioinformatics analysis.
Qian X; Jiang C; Shen S; Zou X
J Cancer; 2021; 12(7):2010-2022. PubMed ID: 33753999
[No Abstract] [Full Text] [Related]
2. The Effect of GPRC5a on the Proliferation, Migration Ability, Chemotherapy Resistance, and Phosphorylation of GSK-3β in Pancreatic Cancer.
Liu B; Yang H; Pilarsky C; Weber GF
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29949874
[TBL] [Abstract][Full Text] [Related]
3. IMUP and GPRC5A: two newly identified risk score indicators in pancreatic ductal adenocarcinoma.
Wei R; Qi G; Zeng Z; Shen N; Wang Z; Shen H; Gao L; Song C; Ma W; Wang C
Cancer Cell Int; 2021 Nov; 21(1):620. PubMed ID: 34819098
[TBL] [Abstract][Full Text] [Related]
4. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y
Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221
[TBL] [Abstract][Full Text] [Related]
5. Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer.
Du Y; Yao K; Feng Q; Mao F; Xin Z; Xu P; Yao J
J Oncol; 2021; 2021():6656337. PubMed ID: 33986805
[TBL] [Abstract][Full Text] [Related]
6. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of reduced GPRC5A expression in surgically resected non-small cell lung cancer.
Jin E; Wang W; Fang M; Wang W; Xie R; Zhou H; Ye J; Xu R; Ma S
Oncol Lett; 2019 Jan; 17(1):502-507. PubMed ID: 30655793
[TBL] [Abstract][Full Text] [Related]
8. GPRC5A facilitates cell proliferation through cell cycle regulation and correlates with bone metastasis in prostate cancer.
Sawada Y; Kikugawa T; Iio H; Sakakibara I; Yoshida S; Ikedo A; Yanagihara Y; Saeki N; Győrffy B; Kishida T; Okubo Y; Nakamura Y; Miyagi Y; Saika T; Imai Y
Int J Cancer; 2020 Mar; 146(5):1369-1382. PubMed ID: 31276604
[TBL] [Abstract][Full Text] [Related]
9. Gprc5a-knockout mouse lung epithelial cells predicts ceruloplasmin, lipocalin 2 and periostin as potential biomarkers at early stages of lung tumorigenesis.
Sun B; Guo W; Hu S; Yao F; Yu K; Xing J; Wang R; Song H; Liao Y; Wang T; Jiang P; Han B; Deng J
Oncotarget; 2017 Feb; 8(8):13532-13544. PubMed ID: 28088789
[TBL] [Abstract][Full Text] [Related]
10. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
Li F; Guo P; Dong K; Guo P; Wang H; Lv X
J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
[No Abstract] [Full Text] [Related]
11. Elevated levels of hsa_circ_006100 in gastric cancer promote cell growth and metastasis via miR-195/GPRC5A signalling.
Liang M; Huang G; Liu Z; Wang Q; Yu Z; Liu Z; Lin H; Li M; Zhou X; Zheng Y
Cell Prolif; 2019 Sep; 52(5):e12661. PubMed ID: 31318114
[TBL] [Abstract][Full Text] [Related]
12. Upregulated GPRC5A disrupting the Hippo pathway promotes the proliferation and migration of pancreatic cancer cells via the cAMP-CREB axis.
Fang W; Yu X; Deng J; Yu B; Xiong J; Ma M
Discov Oncol; 2023 Feb; 14(1):17. PubMed ID: 36735162
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
14. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
Zhou J; Hui X; Mao Y; Fan L
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
[TBL] [Abstract][Full Text] [Related]
15. GPRC5A: An Emerging Biomarker in Human Cancer.
Jiang X; Xu X; Wu M; Guan Z; Su X; Chen S; Wang H; Teng L
Biomed Res Int; 2018; 2018():1823726. PubMed ID: 30417009
[TBL] [Abstract][Full Text] [Related]
16. Elevation of GPRC5A expression in colorectal cancer promotes tumor progression through VNN-1 induced oxidative stress.
Zhang L; Li L; Gao G; Wei G; Zheng Y; Wang C; Gao N; Zhao Y; Deng J; Chen H; Sun J; Li D; Zhang X; Liu M
Int J Cancer; 2017 Jun; 140(12):2734-2747. PubMed ID: 28316092
[TBL] [Abstract][Full Text] [Related]
17. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
[TBL] [Abstract][Full Text] [Related]
18. KAI1 reverses the epithelial-mesenchymal transition in human pancreatic cancer cells.
Liu X; Guo XZ; Li HY; Chen J
Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):471-477. PubMed ID: 30948327
[TBL] [Abstract][Full Text] [Related]
19. GPRC5A promotes paclitaxel resistance and glucose content in NSCLC.
Wang Y; Gao L; Wang F; Yu C; Chen C; Xia C
Anticancer Drugs; 2024 Apr; ():. PubMed ID: 38602327
[TBL] [Abstract][Full Text] [Related]
20. Circadian Genes MBOAT2/CDA/LPCAT2/B4GALT5 in the Metabolic Pathway Serve as New Biomarkers of PACA Prognosis and Immune Infiltration.
Wang Q; Zhou S; Hu X; Wang X; Wu X; Huai Z; Gao Y; Li S
Life (Basel); 2023 Apr; 13(5):. PubMed ID: 37240761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
